Eli Lilly's drug lowers heart disease risk factor in just one dose: Study
Breadcrumb Trail Links Health Lilly’s lepodisiran, given at the highest dose, reduced a heart disease-linked protein to undetectable levels for 48 weeks. Author of the article: Published Nov 13, 2023 • 3 minute read Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Photo by AJ Mast /Bloomberg Article content A single … [Read more…]